A study suggests that a bile acid may be used for the treatment of obesity, insulin resistance, and type 2 diabetes. This discovery was made when researchers found colestimide, a resin that eliminates bile acids, as a cholesterol-lowering treatment.
The study was based on the fact that abnormal lipids lead to high mortality in type 2 diabetics. The researchers investigated the effects of colestimide on blood glucose levels in mice that develop a disease akin to type 2 diabetes. Colestimide treatment prevented diet-induced obesity and high blood sugar, and corrected diet-induced obesity in mice. It also showed a significant decrease in levels of "bad" LDL cholesterol without affecting "good" HDL cholesterol levels.
How about that? The unlikely path of colestimide could detour us from hitting the dead end consequences of high blood fats and obesity. All these discoveries on mice eventually will prove something remarkable for us humans. Won't they?
